Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | ICICI Pru |
| AUM | ₹1,534 Cr | ₹2,721 Cr |
| NAV | ₹38.9215 | ₹11.3700 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 1.9 years |
| Expense ratio | 1.1% | 1.9% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| 1 month | — | +10.60% |
| 3 months | — | +5.38% |
| 6 months | — | +7.67% |
| YTD | — | +1.25% |
| 1 year | — | +1.79% |
| 3 years (CAGR) | — | — |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | — | +6.76% |
Risk
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Volatility | — | — |
| Downside volatility | — | — |
| Sharpe | — | — |
| Sortino | — | — |
| Calmar | — | — |
| Return / risk | — | — |
| Deepest fall | — | −14.01% |
| Days to recover | — | 235 |
| Below its high | — | 0.00% |
Against benchmark
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Best 1-year | — | +17.42% |
| Middle 1-year | — | +1.91% |
| Worst 1-year | — | −8.17% |
| 1-year periods with a loss | — | 22.6% |
| Middle 3-year | — | — |
| Positive months | — | — |
| Best day | — | +3.56% |
| Worst day | — | −3.19% |
| Worst 5% day | — | −1.21% |
| Positive days | — | 45.7% |
| NAVs a year | — | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | — |
| 1-year XIRR | — | +10.68% |
Holdings overlap i
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Tata India Pharma & Healthcare Fund Direct · filing Oct 2026 | — | 6% |
| ICICI Prudential Equity Minimum Variance Fund Direct · filing Oct 2026 | 6% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata India Pharma & Healthcare Fund and ICICI Prudential Equity Minimum Variance Fund
Overlap
6.5%
smaller weight of each shared stock, added up
Stocks in common
4
of 39 and 30
Weight in common
18% · 7%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | Counts toward overlap |
|---|---|---|---|
| Apollo Hospitals Enterprise Limited | 4.55% | 2.82% | 2.82% |
| Sun Pharmaceutical Industries Limited | 7.89% | 2.19% | 2.19% |
| Nestle India Limited | 1.09% | 1.22% | 1.09% |
| Max Healthcare Institute Limited | 4.28% | 0.39% | 0.39% |
| 4 stocks | 17.8% | 6.6% | 6.5% |
Only in Tata India Pharma & Healthcare Fund (35)
| Abbott India Limited | 5.66% |
| Divi's Laboratories Limited | 5.41% |
| Healthcare Global Enterprises Limited | 5.25% |
| Dr. Reddy's Laboratories Limited | 5.14% |
| Torrent Pharmaceuticals Limited | 4.73% |
| Rainbow Childrens Medicare Limited | 4.02% |
| Sai Life Sciences Limited | 3.22% |
| Syngene International Limited | 3.17% |
| Procter & Gamble Health Limited | 3.15% |
| Lupin Limited | 3.13% |
| Cipla Limited | 3.08% |
| Anthem Biosciences Limited | 2.99% |
| Natco Pharma Limited | 2.86% |
| FDC Limited | 2.69% |
| Bayer Cropscience Limited | 2.68% |
| Acutaas Chemicals Limited | 2.40% |
| Pfizer Limited | 2.40% |
| Aster DM Quality Care Limited | 2.33% |
| Biocon Limited | 2.23% |
| Navin Fluorine International Limited | 2.15% |
| Sanofi Consumer Healthcare India Limited | 1.99% |
| Ajanta Pharma Limited | 1.59% |
| Alkem Laboratories Limited | 1.40% |
| Dr Agarwal's Health Care Ltd | 1.31% |
| Gillette India Limited | 1.25% |
and 10 smaller holdings (5.7% of the fund).
Only in ICICI Prudential Equity Minimum Variance Fund (26)
| Reliance Industries Limited | 9.71% |
| HDFC Bank Limited | 7.51% |
| Kotak Mahindra Bank Limited | 7.50% |
| NTPC Limited | 6.85% |
| State Bank of India | 5.41% |
| Bajaj Finserv Limited | 5.39% |
| Hindustan Unilever Limited | 4.66% |
| Asian Paints Limited | 4.36% |
| Titan Company Limited | 3.33% |
| ITC Limited | 3.32% |
| Tata Consumer Products Limited | 2.29% |
| HDFC Life Insurance Company Limited | 2.19% |
| Godrej Consumer Products Limited | 2.05% |
| Britannia Industries Limited | 1.74% |
| SBI Life Insurance Company Limited | 1.73% |
| Life Insurance Corporation Of India | 1.60% |
| Oil & Natural Gas Corporation Limited | 1.58% |
| Axis Bank Limited | 1.52% |
| Grasim Industries Limited | 1.51% |
| Maruti Suzuki India Limited | 1.18% |
| Larsen & Toubro Limited | 1.13% |
| Power Grid Corporation of India Limited | 1.10% |
| Bajaj Holdings & Investment Limited | 0.89% |
| Tata Steel Limited | 0.70% |
| ICICI Bank Limited | 0.58% |
and 1 smaller holdings (0.4% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata India Pharma & Healthcare Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Large companies | 26.8% | 86.5% |
| Mid companies | 30.4% | 0.4% |
| Small companies | 40.2% | — |
| Top 10 holdings | 50.1% | 58.0% |
| Largest sector | Pharmaceuticals & Biotechnology 64% | Banks 23% |